Through literature review, investor presentations, press releases, and pharma/biotech eNewsletters , our team will provide a comprehensive analysis of the competitive marketplace. By assessing current market competition, identifying gaps and opportunities, and evaluating emerging clinical data, our team will provide strategic recommendations to support your overall medical affairs strategy. This analysis can be done as a single point in time or as an ongoing process (e.g. monthly, quarterly) to keep your medical team fully informed of what information is in the public domain from approved agents/regimens and from treatments in development.